跳至主要内容
临床试验/NCT01781169
NCT01781169已完成不适用

Health Effect of Oral Vitamin D Supplementation on Obese Chinese Males

Shenzhen Center for Chronic Disease Control1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2011年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
1
主要终点
Plasma 25-hydroxy Vitamin D (25(OH)D) Level (Nmol/L)

研究概览

简要总结

Hypothesis: Oral Supplementation of Vitamin D can Reduce Hypersecretion of Parathyroid Hormone and Insulin Resistance in Obese Chinese Males.

Protocol: Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) or eight weeks to the obese males compared with the normal-weight males. Index measures were conducted at baseline and endpoint.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
23 Years 至 66 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • body mass index (BMI) ≥ 28kg/m2 or 18.5 ≤ BMI < 24 (kg/m2)
  • non vegetarian Han Chinese and did not smoke, drink, nor take vitamin D supplements for > 2 y
  • fasting serum glucose < 7.0 mmol/L
  • serum glucose of 2 hr after 75 g oral glucose loading < 11.1 mmol/L
  • normal functioning of liver and kidney evaluated by alkaline phosphatase, aspartate aminotransferase, creatinine, and uric acid

排除标准

  • not match the above inclusion criteria
  • diagnosed as having any organic diseases were excluded

结局指标

主要结局

Plasma 25-hydroxy Vitamin D (25(OH)D) Level (Nmol/L)

时间窗: Endpoint and baseline of the 8 weeks' trial

次要结局

未报告次要终点

研究者

发起方
Shenzhen Center for Chronic Disease Control
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhou Ji-Chang

Vice Dean of Molecular Biology Lab

Shenzhen Center for Chronic Disease Control

研究点 (1)

Loading locations...

相似试验